跳至主要内容
临床试验/NCT01438684
NCT01438684暂停1 期

Phase 1 Study of RPh201 in Patients With Chronic Vegetative or Minimal Conscious State

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2012年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
暂停
入组人数
10
试验地点
1
主要终点
consciousness level measured clinically

研究概览

简要总结

The aim is to evaluate the impact of RPh201 on brain activity in chronic vegetative state patients. The assessment will be done using clinical measurements and functional MRI studies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic vegetative state patients

排除标准

  • allergic reaction to treatment
  • patients that can not undergo MRI
  • Pregnancy

研究组 & 干预措施

RPh201 group

Active Comparator

7 patients will receive the treatment

干预措施: RPh201 (Drug)

non RPh201 group

Placebo Comparator

3 patients will receive placebo

干预措施: Saline (Drug)

结局指标

主要结局

consciousness level measured clinically

时间窗: 6 months

Each patient will undergo a behavioral assessment (using the Coma Recovery Scale Revised) before treatment and every 2 weeks during the treatment period as well as 3 months following the end of the treatment. Complete blood counts, electrolytes, liver function tests, renal function tests and ECG will be performed every two weeks.

次要结局

  • Functional magnetic resonance imaging of cortical activity(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验